Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 69Terminated 11Unknown 9Recruiting 8Active not recruiting 3Not yet recruiting 2Withdrawn 1No longer available 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 4Sarcoma 2Myeloid 2Gastrointestinal 2Lymphoid 1

Conditions

Gastrointestinal Stromal Tumors 2Piebaldism 1

Interventions

Doxorubicin 5Cyclophosphamide 4anlotinib 3Vincristine 3Temozolomide 3Specimen Handling 3Magnetic Resonance Spectroscopy 3Injections 3polatuzumab vedotin 2liposomal doxorubicin 2glofitamab 2envafolimab 2X-Rays 2Radiotherapy 2Prednisone 2Nivolumab 2Neoadjuvant Therapy 2Imatinib Mesylate 2Biopsy 2AZD 6244 2toripalimab 1surufatinib 1spartalizumab 1relmacabtagene autoleucel 1regorafenib 1penpulimab 1pemigatinib 1pazopanib 1obinutuzumab 1montelukast 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Imatinib Mesylate × Sarcoma × Clear all
NCT07585266 2026-05-13

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

GlaxoSmithKline

Phase 3 Not yet recruiting
800 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05970900 2023-08-01

PIRKER

Fujian Medical University Union Hospital

Phase 3 Not yet recruiting
23 enrolled
GastrointestinalSarcoma

Piebaldism, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡